AI-Powered Research

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 6 locations

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

Phase 2

Recruiting

Conditions: Bladder Cancer

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Procedure: Radical cystectomy

First Posted Date: 2018-05-09

Last Posted Date: 2025-04-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT03520491

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases

Phase 1

Completed

Conditions: Leptomeningeal Metastases

Interventions: Radiation: Proton craniospinal irradiation (CSI)

First Posted Date: 2018-05-09

Last Posted Date: 2022-12-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT03520504

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 5 locations

Pilot Trial of the Robotic Uterine Manipulator

Not Applicable

Completed

Conditions: Gynecologic Surgery

Interventions: Device: BAUM device

First Posted Date: 2018-05-07

Last Posted Date: 2024-08-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT03517228

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent only), Harrison, New York, United States

and more 4 locations

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

Not Applicable

Completed

Conditions: Multiple Myeloma

Interventions: Diagnostic Test: Structural Image
Diagnostic Test: Functional Image
Behavioral: Digit Span subtest
Behavioral: Brief Test of Attention
Behavioral: Trail Making Test (Parts A & B)
Behavioral: Auditory Consonant Trigrams Test
Behavioral: Controlled Oral Word Association Test
Behavioral: Hopkins Verbal Learning Test-Revised
Behavioral: The Center for Epidemiological Study-Depression
Behavioral: The Functional Assessment of Chronic Illness Therapy-Fatigue Subscale, Version 4
Other: Blood draw

First Posted Date: 2018-04-26

Last Posted Date: 2024-03-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03508765

Locations: 🇺🇸
Rutgers University - Data Analysis, New Brunswick, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Early Staged Consent Before Prostate Biopsy

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Meditation
Procedure: Prostate Biopsy
Behavioral: Questionnaires

First Posted Date: 2018-04-25

Last Posted Date: 2024-10-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 390

Registration Number: NCT03507725

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

Phase 2

Recruiting

Conditions: Bladder Cancer

Interventions: Drug: Pembrolizumab (MK-3475)
Drug: Bacillus Calmette-Guérin (BCG)

First Posted Date: 2018-04-20

Last Posted Date: 2025-05-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT03504163

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (All protocol activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

QI: Patient Satisfaction With Facial Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

Conditions: Skin Cancer

First Posted Date: 2018-04-19

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3000

Registration Number: NCT03503240

Locations: 🇺🇸
Brigham and Women's Hospital (Data Collection Only), Boston, Massachusetts, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 2 locations

Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently

Completed

Conditions: Glioma of Brain
Glioma of Spinal Cord
Glioma

Interventions: Diagnostic Test: Language paradigms + RS fMRI + one anatomical sequence
Behavioral: Multilingual Aphasia Examination
Diagnostic Test: Language paradigms + RS fMRI

First Posted Date: 2018-04-12

Last Posted Date: 2025-05-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 32

Registration Number: NCT03496181

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
City College of New York, New York, New York, United States
🇮🇹
IMT School of Advance Studies Lucca, Lucca, Lucca LU, Italy

Home Terms & Conditions Privacy Policy